Mingjun Yu

520 total citations
23 papers, 278 citations indexed

About

Mingjun Yu is a scholar working on Cancer Research, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Mingjun Yu has authored 23 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 6 papers in Molecular Biology and 4 papers in Organic Chemistry. Recurrent topics in Mingjun Yu's work include Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Mingjun Yu is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Mingjun Yu collaborates with scholars based in China and United States. Mingjun Yu's co-authors include Shijia Yu, Juan Feng, Zhongqi Bu, Xin He, Lulu Wen, Pingping He, Yunhui Liu, Wen Zhou, Duo Chen and Risheng Yao and has published in prestigious journals such as Neurobiology of Disease, Frontiers in Pharmacology and Aging Cell.

In The Last Decade

Mingjun Yu

21 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingjun Yu China 10 167 147 61 22 17 23 278
Shijia Yu China 10 183 1.1× 143 1.0× 63 1.0× 37 1.7× 36 2.1× 15 345
Deqin Wu China 8 164 1.0× 125 0.9× 39 0.6× 21 1.0× 15 0.9× 10 287
Jianhong Han China 6 227 1.4× 178 1.2× 35 0.6× 9 0.4× 27 1.6× 11 342
Amruta Singh India 8 200 1.2× 51 0.3× 78 1.3× 20 0.9× 14 0.8× 11 284
Zhidong Yuan China 10 312 1.9× 194 1.3× 23 0.4× 20 0.9× 11 0.6× 22 438
Wenjun Ji China 10 183 1.1× 60 0.4× 44 0.7× 13 0.6× 7 0.4× 25 303
Ashhar Ali United States 10 199 1.2× 121 0.8× 21 0.3× 18 0.8× 11 0.6× 29 383
Ying Feng China 10 189 1.1× 88 0.6× 19 0.3× 26 1.2× 10 0.6× 20 291
Bhagyashri Kulkarni India 4 205 1.2× 171 1.2× 20 0.3× 14 0.6× 9 0.5× 8 282
Pablo Fernández‐Tussy United States 8 109 0.7× 97 0.7× 54 0.9× 12 0.5× 11 0.6× 10 235

Countries citing papers authored by Mingjun Yu

Since Specialization
Citations

This map shows the geographic impact of Mingjun Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjun Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjun Yu more than expected).

Fields of papers citing papers by Mingjun Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingjun Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjun Yu. The network helps show where Mingjun Yu may publish in the future.

Co-authorship network of co-authors of Mingjun Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Mingjun Yu. A scholar is included among the top collaborators of Mingjun Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingjun Yu. Mingjun Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Ping, Pei Li, Yong Ren, et al.. (2025). CRISPR-based epigenetic editing of Gad1 improves synaptic inhibition and cognitive behavior in a Tauopathy mouse model. Neurobiology of Disease. 206. 106826–106826. 4 indexed citations
2.
Xian, Hang, Yuanying Liu, Jianlei Zhang, et al.. (2023). Peripheral BDNF Regulates Somatosensory–Sympathetic Coupling in Brachial Plexus Avulsion-Induced Neuropathic Pain. Neuroscience Bulletin. 39(12). 1789–1806. 9 indexed citations
3.
Yu, Shijia, et al.. (2022). LncRNA KCNQ1OT1 predicts further cerebral events in patients with transient ischemic attack. Frontiers in Pharmacology. 13. 961190–961190. 2 indexed citations
4.
Yu, Mingjun, Chao Li, Shengsong Deng, Xiao‐Ming Meng, & Risheng Yao. (2022). Discovery of a novel GRPR antagonist for protection against cisplatin-induced acute kidney injury. Bioorganic Chemistry. 124. 105794–105794. 1 indexed citations
5.
Zhu, Yuting, Mingjun Yu, Chao Li, et al.. (2022). Design, Synthesis and Biological Evaluation of Novel 1, 3, 4-Oxadiazole PD176252Analogues as Potential GRPR Inhibitors. Anti-Cancer Agents in Medicinal Chemistry. 22(17). 3009–3024.
6.
Yu, Mingjun, et al.. (2021). HOXC6/8/10/13 predict poor prognosis and associate with immune infiltrations in glioblastoma. International Immunopharmacology. 101(Pt A). 108293–108293. 10 indexed citations
7.
Yu, Mingjun, et al.. (2021). In-situreactive heat breaking cell wall by SO3hydration: innovative cell-wall breaking technique to enhance extraction of cinnamaldehyde from cinnamon. Preparative Biochemistry & Biotechnology. 51(9). 833–841. 4 indexed citations
8.
Li, Hao, et al.. (2021). LOXL1‐AS1 communicating with TIAR modulates vasculogenic mimicry in glioma via regulation of the miR‐374b‐5p/MMP14 axis. Journal of Cellular and Molecular Medicine. 26(2). 475–490. 17 indexed citations
9.
Feng, Juan, et al.. (2020). MicroRNA-670 aggravates cerebral ischemia/reperfusion injury via the Yap pathway. Neural Regeneration Research. 16(6). 1024–1024. 15 indexed citations
10.
Yu, Shijia & Mingjun Yu. (2020). Severe Acute Respiratory Syndrome Coronavirus 2-Induced Neurological Complications. Frontiers in Cell and Developmental Biology. 8. 605972–605972. 10 indexed citations
11.
Yu, Shijia, Mingjun Yu, Zhongqi Bu, Pingping He, & Juan Feng. (2020). FKBP5 Exacerbates Impairments in Cerebral Ischemic Stroke by Inducing Autophagy via the AKT/FOXO3 Pathway. Frontiers in Cellular Neuroscience. 14. 193–193. 34 indexed citations
12.
Yu, Mingjun, et al.. (2020). Linc00475 promotes the progression of glioma by regulating the miR‐141‐3p/YAP1 axis. Journal of Cellular and Molecular Medicine. 25(1). 463–472. 15 indexed citations
13.
Yu, Mingjun, et al.. (2019). Knockdown of linc01023 restrains glioma proliferation, migration and invasion by regulating IGF-1R/AKT pathway. Journal of Cancer. 10(13). 2961–2968. 15 indexed citations
14.
Yu, Mingjun, et al.. (2019). Dual Anti-cancer and Anti-Itch Activity of PD176252 Analogues: Design, Synthesis and Biological Evaluation. Anti-Cancer Agents in Medicinal Chemistry. 19(8). 992–1001. 5 indexed citations
15.
Wei, Biao, et al.. (2019). Design, synthesis and evaluation of PD176252 analogues for ameliorating cisplatin-induced nephrotoxicity. MedChemComm. 10(5). 757–763. 6 indexed citations
16.
Yu, Mingjun, et al.. (2018). Over-Expressed FEZF1 Predicts a Poor Prognosis in Glioma and Promotes Glioma Cell Malignant Biological Properties by Regulating Akt-ERK Pathway. Journal of Molecular Neuroscience. 65(4). 411–419. 12 indexed citations
17.
Yu, Mingjun, et al.. (2018). Anti-inflammatory Effects of a Small Molecule Gastrin-Releasing Peptide Receptor Antagonist on Adjuvant-Induced Rheumatoid Arthritis in Rats. Chemical and Pharmaceutical Bulletin. 66(4). 410–415. 2 indexed citations
18.
Yu, Mingjun, et al.. (2018). An efficient and green process for the synthesis of 5-methyl-2-nitrobenzoic acid. Research on Chemical Intermediates. 44(4). 2751–2759.
19.
20.
Qiu, Hong, Yimou Wu, Xiaoxing You, Mingjun Yu, & Yanhua Zeng. (2007). [Mycoplasma genitalium lipid-associated membrane proteins induce human monocytic cell express proinflammatory cytokines and apoptosis by activating nuclear factor kappaB].. PubMed. 47(5). 899–904. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shijia Yu Breakdown of academic impact, for papers by Deqin Wu Breakdown of academic impact, for papers by Jianhong Han Breakdown of academic impact, for papers by Amruta Singh Breakdown of academic impact, for papers by Zhidong Yuan Breakdown of academic impact, for papers by Wenjun Ji Breakdown of academic impact, for papers by Ashhar Ali Breakdown of academic impact, for papers by Ying Feng Breakdown of academic impact, for papers by Bhagyashri Kulkarni Breakdown of academic impact, for papers by Pablo Fernández‐Tussy
Rankless by CCL
2026